Virtu KCG Holdings’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Virtu KCG Holdings’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-15,208	Closed	-$318K	–	4134
2016 Q3	$318K	Buy	+15,208	New	+$175K	0.01%	1864
2015 Q1	–	Sell	-11,295	Closed	-$188K	–	4297
2014 Q4	$188K	Buy	+11,295	New	+$165K	﹤0.01%	2920

Virtu KCG Holdings's VTAE Position: Q4 2016 in Review

Virtu KCG Holdings sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 15,208 shares — an estimated $318K sold.

Virtu KCG Holdings first reported a position in VTAE in Q4 2014 and held it in 2 quarters. The position peaked at $318K in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Virtu KCG Holdings reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Virtu KCG Holdings sold 15,208 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $318K.
Virtu KCG Holdings first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q4 2014 and held it in 2 quarters.
Virtu KCG Holdings's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $318K in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Virtu KCG Holdings's 13F filing for Q4 2016, filed 10 Feb 2017.